Mod GRF, Ipamorelin 10mg (Blend)

Peptide Science research editorial team.

Mod GRF plus Ipamorelin 10mg Blend Overview

Mod GRF plus Ipamorelin 10mg Blend from Peptide Science is the dual-active lyophilised vial pairing the modified GHRH analogue Mod GRF 1-29 with Ipamorelin, the selective 5-amino-acid pentapeptide ghrelin-receptor agonist. This is the equivalent of the more commonly cited CJC-1295 No DAC plus Ipamorelin pairing using the Mod GRF naming convention.

Combined Pathway Background

Ipamorelin is characterised in preclinical literature for selective GH-release activity at GHS-R1a with reported low cortisol and prolactin response, distinguishing it from the broader-spectrum GHRP-2, GHRP-6, and Hexarelin compounds. Combined with Mod GRF 1-29 acting through the GHRH-receptor pathway, the blend is the standard reference clean-readout combination for additive-secretagogue research. Browse the broader growth-hormone peptide range.

Vial Specifications

Reconstitution and Handling

The dual-active vial reconstitutes with bacteriostatic water at the working concentration set by the principal investigator. For the equivalent CJC-1295-naming variant, see CJC-1295 No DAC plus Ipamorelin 10mg Blend.

Quality and Shipping

Each batch passes HPLC at greater than 99 percent for each active, with mass-spectrometry confirmation. A Certificate of Analysis accompanies every order listing each active and its measured purity. Material is filled in a US laboratory under ISO 9001:2015-aligned quality systems and dispatched in temperature-monitored insulated packaging.

For laboratory research and development use only. Not for human or veterinary consumption. Has not been evaluated by the U.S. Food and Drug Administration and is not intended to diagnose, treat, cure, or prevent any disease. Purchasers acknowledge they are qualified researchers age 21 or older and accept responsibility for compliance with all applicable federal, state, and local laws.